{"id":"https://openalex.org/W3130036614","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","title":"Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2\u2212 early breast cancer (eBC)","display_name":"Abstract PS7-23: Neoadjuvant and adjuvant therapy (NAT/AT) treatment patterns and clinical characteristics in a real-world cohort of US patients with HR+/HER2\u2212 early breast cancer (eBC)","publication_year":2021,"publication_date":"2021-02-15","ids":{"openalex":"https://openalex.org/W3130036614","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","mag":"3130036614"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs20-ps7-23","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026112274","display_name":"Mary Kathryn Downer","orcid":"https://orcid.org/0000-0003-0272-9228","observed_orcids":["https://orcid.org/0000-0003-0272-9228"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary K Downer","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004551825","display_name":"Christopher Craggs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Craggs","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Preet Dhillon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Preet Dhillon","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083429391","display_name":"Patricia Luhn","orcid":"https://orcid.org/0000-0002-8889-0217","observed_orcids":["https://orcid.org/0000-0002-8889-0217"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia Luhn","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027417787","display_name":"Carlos Flores-Avile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Flores-Avile","raw_affiliation_strings":["2Genesis Research, Hoboken, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genesis Research, Hoboken, NJ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075230015","display_name":"Amie Tan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amie Tan","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068295835","display_name":"Monika Patre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Monika Patre","raw_affiliation_strings":["3F. Hoffmann-La Roche AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054043060","display_name":"Frauke Schimm\u00f6ller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frauke Schimmoller","raw_affiliation_strings":["1Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083418555","display_name":"Tanja Badovinac \u010crnjevi\u0107","orcid":"https://orcid.org/0000-0002-0922-3409","observed_orcids":["https://orcid.org/0000-0002-0922-3409"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Tanja Badovinac Crnjevic","raw_affiliation_strings":["3F. Hoffmann-La Roche AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3F. Hoffmann-La Roche AG, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"4_Supplement","first_page":"PS7","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hr-her2-early-breast-cancer","display_name":"HR+/HER2- early breast cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.949999988079071},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7360000014305115},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9129999876022339},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.503000020980835},{"id":"https://openalex.org/keywords/anthracyclines","display_name":"anthracyclines","score":0.6150000095367432},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.781000018119812},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.9419999718666077},{"id":"https://openalex.org/keywords/mastectomy","display_name":"mastectomy","score":0.6600000262260437},{"id":"https://openalex.org/keywords/breast-conserving-surgery","display_name":"breast-conserving surgery","score":0.8299999833106995},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.5320000052452087},{"id":"https://openalex.org/keywords/treatment-utilization-trends","display_name":"treatment utilization trends","score":0.367000013589859},{"id":"https://openalex.org/keywords/real-world-data","display_name":"real-world data","score":0.6809999942779541},{"id":"https://openalex.org/keywords/flatiron-health","display_name":"Flatiron Health","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8134260177612305},{"id":"https://openalex.org/C182516595","wikidata":"https://www.wikidata.org/wiki/Q376660","display_name":"Nat","level":2,"score":0.7971078753471375},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6743077039718628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5647992491722107},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.533042848110199},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5183854699134827},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4743165671825409},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.44679051637649536},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.438308984041214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39695635437965393},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs20-ps7-23","doi":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs20-ps7-23","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2589682239","https://openalex.org/W4400273578","https://openalex.org/W4387370230","https://openalex.org/W4402722274","https://openalex.org/W4411288399","https://openalex.org/W4361190733","https://openalex.org/W3130296732","https://openalex.org/W4396499733","https://openalex.org/W3027957849","https://openalex.org/W4387808771"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Treatment":[2],"patterns":[3,48,67,567],"in":[4,39,68,95,126,183,206,234,238,335,343,347,380,519,571],"hormone":[5],"receptor":[6,11],"(HR)+/human":[7],"epidermal":[8],"growth":[9],"factor":[10],"2":[12],"(HER2)\u2212":[13],"eBC":[14,86,115,128,398,420,443],"continue":[15],"to":[16,33,61,236,276],"evolve.":[17],"While":[18],"AT":[19,148,215,222,287,317,329,401],"remains":[20,330],"the":[21,96,127,177,184,197,207,331,356,588],"standard":[22,332],"of":[23,55,114,119,133,166,179,199,226,266,378,394,442,516,575,587],"care,":[24],"NAT":[25,40,138,191,212,229,267,272,292,344,351,361,379,386],"has":[26,345,353],"been":[27],"indicated":[28],"as":[29,141,151,176,385],"a":[30,278,367,572],"viable":[31],"approach":[32,334],"downstage":[34],"higher-stage":[35],"tumors.":[36],"As":[37],"interest":[38,342],"trials":[41],"increases,":[42],"detailed":[43],"data":[44],"on":[45],"current":[46],"treatment":[47,66,125,135,143,153,333,405,410,566],"may":[49,387],"inform":[50],"future":[51],"research.":[52],"The":[53,224,289,314,514],"objective":[54],"this":[56,381],"retrospective":[57],"observational":[58],"study":[59],"was":[60,139,149,174,193],"evaluate":[62],"patient":[63],"characteristics":[64,570],"and":[65,91,117,123,186,192,218,257,350,362,562,568],"US":[69,336,576],"patients":[70,106,161,205,227,284,395,517,528,577],"diagnosed":[71,80,518,529],"with":[72,81,131,162,283,396,537,578],"HR+/HER2\u2212":[73,108,340,397,579],"eBC.":[74],"Methods:":[75],"This":[76],"analysis":[77],"included":[78,294,527],"adults":[79],"non-metastatic":[82],"(stage":[83],"I-III)":[84],"invasive":[85,181,497,501],"between":[87],"January":[88],"1,":[89,93],"2011,":[90],"March":[92,531],"2019,":[94],"nationwide":[97],"Flatiron":[98],"Health":[99],"electronic":[100],"health":[101],"record\u2013derived":[102],"de-identified":[103],"database.":[104],"All":[105],"had":[107,248,263],"test":[109],"results":[110],"within":[111,154],"90":[112],"days":[113],"diagnosis":[116],"evidence":[118],"both":[120],"primary":[121,146,158,200],"surgery":[122,159,478],"systemic":[124,142,152],"setting.":[129],"Patients":[130,246,269],"records":[132],"HER2-targeted":[134],"were":[136,259,273,319],"excluded.":[137],"defined":[140,150,175],"before":[144,411],"first":[145],"surgery;":[147],"12":[155],"months":[156,165],"after":[157,168,190,406],"among":[160],"\u2265":[163],"6":[164],"follow-up":[167],"surgery.":[169,201],"Pathologic":[170],"complete":[171,512],"response":[172],"(pCR)":[173],"absence":[178],"residual":[180],"disease":[182],"breast":[185,494,581],"axillary":[187],"lymph":[188],"nodes":[189],"subsequently":[194],"confirmed":[195],"at":[196,419],"time":[198],"Results:":[202],"Among":[203],"4739":[204],"study,":[208],"341":[209],"(7%)":[210],"received":[211,214,221,271,286,400],"(318/341":[213],"following":[216,360],"NAT)":[217],"4398":[219],"(93%)":[220],"only.":[223,288],"proportion":[225],"receiving":[228],"increased":[230],"annually":[231],"from":[232],"5%":[233],"2011":[235],"9%":[237],"2018.":[239],"Of":[240],"NAT-treated":[241],"patients,":[242],"7%":[243],"achieved":[244],"pCR.":[245],"who":[247,258,270,285,399],"higher":[249,252,264],"pathology":[250],"stage,":[251],"tumor":[253],"grade,":[254],"younger":[255],"age":[256],"Black":[260],"or":[261,305,325,402],"Hispanic/Latino":[262],"proportions":[265],"(Table).":[268],"more":[274,390],"likely":[275],"receive":[277],"mastectomy":[279],"(vs":[280],"lumpectomy)":[281],"compared":[282],"most":[290,315],"common":[291,316],"regimens":[293,318],"chemotherapy":[295],"(54%;":[296],"primarily":[297,310,323],"anthracycline":[298],"+":[299,301],"cyclophosphamide":[300],"taxane":[302],"[ACT]":[303],"regimens)":[304],"endocrine":[306],"(ET)":[307],"monotherapy":[308,321],"(36%;":[309],"aromatase":[311],"inhibitor":[312],"[AI]).":[313],"ET":[320],"(79%;":[322],"AI":[324],"tamoxifen).":[326],"Conclusions:":[327],"Although":[328],"clinical":[337,376,569],"practice":[338],"for":[339,370],"eBC,":[341,492],"grown":[346],"recent":[348],"years":[349],"use":[352],"increased.":[354],"Given":[355],"low":[357,523],"pCR":[358,364],"rates":[359],"since":[363],"is":[365,383,521,535],"considered":[366],"surrogate":[368],"marker":[369],"survival,":[371],"further":[372],"investigation":[373],"into":[374],"longer-term":[375],"benefits":[377],"population":[382],"warranted":[384],"be":[388],"becoming":[389],"common.":[391],"Table.":[392],"Characteristics":[393],"NATAT":[403],"only(first":[404],"surgery)N":[407,412],"=":[408,413],"4398NAT(first":[409],"341pCR":[414],"achievedYesNA25":[415],"(7.3)NoNA271":[416],"(79)UnknownNA45":[417],"(13)Age":[418],"diagnosisMedian":[421],"(IQR),":[422],"years64":[423],"(54-72)59":[424],"(49-68)RaceNon-Hispanic":[425],"White2975":[426],"(68)208":[427],"(61)Non-Hispanic":[428],"Black278":[429],"(6.3)31":[430],"(9.1)Non-Hispanic":[431],"Asian120":[432],"(2.7)13":[433],"(3.8)Non-Hispanic":[434],"other428":[435],"(9.7)27":[436],"(7.9)Hispanic/Latino282":[437],"(6.4)39":[438],"(11)Unknown315":[439],"(7.2)23":[440],"(6.7)Year":[441],"diagnosis2011/20121023":[444],"(23)53":[445],"(16)2013/20141136":[446],"(26)81":[447],"(24)2015/20161129":[448],"(26)101":[449],"(30)2017/2018/201911100":[450],"(25)106":[451],"(31)Pathology":[452],"group":[453],"stageI2370":[454],"(54)70":[455],"(21)II1209":[456],"(27)86":[457],"(25)III282":[458],"(6.4)58":[459],"(17)Unknown537":[460],"(12)127":[461],"(37)Tumor":[462],"grade11268":[463],"(29)41":[464],"(12)22297":[465],"(52)186":[466],"(55)3768":[467],"(17)111":[468],"(33)Unknown65":[469],"(1.5)3":[470],"(0.9)HistologyIDC3486":[471],"(79)267":[472],"(78)ILC615":[473],"(14)51":[474],"(15)Other/Unknown297":[475],"(6.8)23":[476],"(6.7)Primary":[477],"typeLumpectomy2911":[479],"(66)128":[480],"(38)Mastectomy1487":[481],"(34)213":[482],"(62)Data":[483],"are":[484],"n":[485],"(%)":[486],"unless":[487],"otherwise":[488],"specified.AT,":[489],"adjuvant":[490,563],"chemotherapy;":[491,509],"early":[493,580],"cancer;":[495],"IDC,":[496],"ductal":[498],"carcinoma;":[499,503],"ILC,":[500],"lobular":[502],"NA,":[504],"not":[505],"applicable,":[506],"NAT,":[507],"neoadjuvant":[508],"pCR,":[510],"pathologic":[511],"response.*":[513],"number":[515],"2019":[520,534],"very":[522],"because":[524],"we":[525],"only":[526],"through":[530],"2019;":[532],"thus":[533],"grouped":[536],"2017/18.":[538],"Citation":[539],"Format:":[540],"Mary":[541],"K":[542],"Downer,":[543],"Christopher":[544],"Craggs,":[545],"Preet":[546],"Dhillon,":[547],"Patricia":[548],"Luhn,":[549],"Carlos":[550],"Flores-Avile,":[551],"Amie":[552],"Tan,":[553],"Monika":[554],"Patre,":[555],"Frauke":[556],"Schimmoller,":[557],"Tanja":[558],"Badovinac":[559],"Crnjevic.":[560],"Neoadjuvant":[561],"therapy":[564],"(NAT/AT)":[565],"real-world":[573],"cohort":[574],"cancer":[582],"(eBC)":[583],"[abstract].":[584],"In:":[585],"Proceedings":[586],"2020":[589,596],"San":[590,599],"Antonio":[591],"Breast":[592],"Cancer":[593,605],"Virtual":[594],"Symposium;":[595],"Dec":[597],"8-11;":[598],"Antonio,":[600],"TX.":[601],"Philadelphia":[602],"(PA):":[603],"AACR;":[604],"Res":[606],"2021;81(4":[607],"Suppl):Abstract":[608],"nr":[609],"PS7-23.":[610]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-03-01T00:00:00"}